Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, April 28, 2023
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
[ Fri, Apr 28th 2023
] - WOPRAI
Ami Fadia Reiterated (AVDL) at Strong Buy and Held Target at $12 on, Apr 28th, 2023
Ami Fadia of Needham, Reiterated "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy and Held Target at $12 on, Apr 28th, 2023.
Ami has made no other calls on AVDL in the last 4 months.
There are 2 other peers that have a rating on AVDL. Out of the 2 peers that are also analyzing AVDL, 0 agree with Ami's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Ami
- Francois Brisebois of "Oppenheimer" Reiterated at Buy and Held Target at $20 on, Monday, April 3rd, 2023
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $14 on, Thursday, March 23rd, 2023
